Literature DB >> 31215020

Gut IgA abundance in adult life is a major determinant of resistance to dextran sodium sulfate-colitis and can compensate for the effects of inadequate maternal IgA received by neonates.

Suman Gupta1, Srijani Basu1, Vineeta Bal1, Satyajit Rath1, Anna George1.   

Abstract

Studies with gene-deficient and gnotobiotic mice have identified many host and microbial factors that contribute to induced colitis, but information on whether specific factors determine susceptibility under more physiological conditions is lacking. Using wild-type strains that differ in their IgA response but harbor a diverse gut microbiome, we found that the IgA-high strain CBA/CaJ (CBA) is resistant to acute colitis induced with dextran sodium sulfate (DSS), unlike the IgA-low strain C57BL/6 (B6). Resistance was associated with extensive IgA-coating of fecal bacteria, lower fecal bacterial loads and greater abundance of barrier-protective transcripts in colonic tissues under homeostatic conditions. Fecal microbial transplant (FT) experiments revealed that disease induction in B6 mice was associated with a cohort of bacteria that are not targeted by IgA. However, CBA mice continued to be resistant to colitis induction following FTs from B6 mice, indicating that they are able to contain such colitogenic members. In support of a role for bacterial exclusion in resistance, oral administration of immunoglobulins decreased DSS-induced disease in B6 mice. In F1 mice derived separately with CBA and B6 dams and in F1 mice backcrossed to the two parental strains, resistance segregated with the IgA response of the pups and not with barrier-associated transcripts or bacterial loads. Interestingly, B6 pups foster-nursed on CBA dams continued to be susceptible in later life, whereas CBA pups foster-nursed on B6 dams continued to be resistant. Together, the data indicate that a high-IgA response in adult life can protect against colitis and compensate for IgA deficiency in early life.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  F1 mice; backcrosses; colitis; fecal microbial transplants; foster nursing

Mesh:

Substances:

Year:  2019        PMID: 31215020      PMCID: PMC6700465          DOI: 10.1111/imm.13091

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

Review 1.  N-Glycans on secretory component: mediators of the interaction between secretory IgA and gram-positive commensals sustaining intestinal homeostasis.

Authors:  Amandine Mathias; Blaise Corthésy
Journal:  Gut Microbes       Date:  2011-09-01

2.  Increased sensitivity to dextran sodium sulfate colitis in IRE1beta-deficient mice.

Authors:  A Bertolotti; X Wang; I Novoa; R Jungreis; K Schlessinger; J H Cho; A B West; D Ron
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 3.  Mucosal innate immune cells regulate both gut homeostasis and intestinal inflammation.

Authors:  Yosuke Kurashima; Yoshiyuki Goto; Hiroshi Kiyono
Journal:  Eur J Immunol       Date:  2013-10-23       Impact factor: 5.532

4.  Importance and regulation of the colonic mucus barrier in a mouse model of colitis.

Authors:  J Petersson; O Schreiber; G C Hansson; S J Gendler; A Velcich; J O Lundberg; S Roos; L Holm; M Phillipson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-25       Impact factor: 4.052

5.  Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis.

Authors:  M Mähler; I J Bristol; E H Leiter; A E Workman; E H Birkenmeier; C O Elson; J P Sundberg
Journal:  Am J Physiol       Date:  1998-03

6.  IgA response to symbiotic bacteria as a mediator of gut homeostasis.

Authors:  Daniel A Peterson; Nathan P McNulty; Janaki L Guruge; Jeffrey I Gordon
Journal:  Cell Host Microbe       Date:  2007-11-15       Impact factor: 21.023

7.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.

Authors:  Ken Sugimoto; Atsuhiro Ogawa; Emiko Mizoguchi; Yasuyo Shimomura; Akira Andoh; Atul K Bhan; Richard S Blumberg; Ramnik J Xavier; Atsushi Mizoguchi
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

8.  Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis.

Authors:  Ana Izcue; Sophie Hue; Sofia Buonocore; Carolina V Arancibia-Cárcamo; Philip P Ahern; Yoichiro Iwakura; Kevin J Maloy; Fiona Powrie
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

9.  Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation.

Authors:  Konrad Aden; Ateequr Rehman; Maren Falk-Paulsen; Thomas Secher; Jan Kuiper; Florian Tran; Steffen Pfeuffer; Raheleh Sheibani-Tezerji; Alexandra Breuer; Anne Luzius; Marlene Jentzsch; Robert Häsler; Susanne Billmann-Born; Olga Will; Simone Lipinski; Richa Bharti; Timon Adolph; Juan L Iovanna; Sarah L Kempster; Richard S Blumberg; Stefan Schreiber; Burkhard Becher; Mathias Chamaillard; Arthur Kaser; Philip Rosenstiel
Journal:  Cell Rep       Date:  2016-08-11       Impact factor: 9.423

Review 10.  Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.

Authors:  Eva Martini; Susanne M Krug; Britta Siegmund; Markus F Neurath; Christoph Becker
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-03-23
View more
  5 in total

1.  Immunoglobulin A Glycosylation and Its Role in Disease.

Authors:  Alyssa L Hansen; Colin Reily; Jan Novak; Matthew B Renfrow
Journal:  Exp Suppl       Date:  2021

2.  Depletion of dietary aryl hydrocarbon receptor ligands alters microbiota composition and function.

Authors:  Kyle M Brawner; Venkata A Yeramilli; Lennard W Duck; William Van Der Pol; Lesley E Smythies; Casey D Morrow; Charles O Elson; Colin A Martin
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

3.  Lactobacillus fermentum Stimulates Intestinal Secretion of Immunoglobulin A in an Individual-Specific Manner.

Authors:  Liya Mei; Ying Chen; Jialiang Wang; Jian Lu; Jianxin Zhao; Hao Zhang; Gang Wang; Wei Chen
Journal:  Foods       Date:  2022-04-25

Review 4.  Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections.

Authors:  Isabelle Bekeredjian-Ding
Journal:  Front Immunol       Date:  2020-08-05       Impact factor: 7.561

Review 5.  Investigating causality with fecal microbiota transplantation in rodents: applications, recommendations and pitfalls.

Authors:  Cassandra E Gheorghe; Nathaniel L Ritz; Jason A Martin; Hannah R Wardill; John F Cryan; Gerard Clarke
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.